DK155326B - METHOD FOR PREPARING 1,4-BENZODIAZEPIN-2-ON DERIVATIVES - Google Patents

METHOD FOR PREPARING 1,4-BENZODIAZEPIN-2-ON DERIVATIVES Download PDF

Info

Publication number
DK155326B
DK155326B DK457773AA DK457773A DK155326B DK 155326 B DK155326 B DK 155326B DK 457773A A DK457773A A DK 457773AA DK 457773 A DK457773 A DK 457773A DK 155326 B DK155326 B DK 155326B
Authority
DK
Denmark
Prior art keywords
ammonia
reflux
formula
compound
reaction mixture
Prior art date
Application number
DK457773AA
Other languages
Danish (da)
Other versions
DK155326C (en
Inventor
George Oswald Chase
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK155326B publication Critical patent/DK155326B/en
Application granted granted Critical
Publication of DK155326C publication Critical patent/DK155326C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • C07D243/28Preparation including building-up the benzodiazepine skeleton from compounds containing no hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • C07D243/30Preparation including building-up the benzodiazepine skeleton from compounds already containing hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Description

DK 155326 BDK 155326 B

Den foreliggende opfindelse angår en særlig fremgangsmåde til fremstilling af l,4-benzodiazepin-2-on-deri-vater med den almene formel 5 R2 0 CUJ> riX b 10 i hvilken R1 betegner hydrogen, halogen, nitro eller tri-fluormethyl, R2 betyder hydrogen eller alkyl med 1-5 car-bonatomer , og R3 betegner phenyl, o-halogenphenyl eller 2- 15 pyridyl, ved omsætning af en forbindelse med den almene formel oThe present invention relates to a particular process for the preparation of 1,4-benzodiazepine-2-one derivatives of general formula 5 wherein R 1 represents hydrogen, halogen, nitro or trifluoromethyl, R 2 represents hydrogen or alkyl of 1 to 5 carbon atoms and R 3 represents phenyl, o-halophenyl or 2- 15 pyridyl, by reacting a compound of the general formula o

R 0 N-C-CH2XR 0 N-C-CH 2 X

20 IIII

25 i hvilken R1, R2 og R3 har den ovenfor angivne betydning, og X betegner chlor, brom eller iod, fortrinsvis chlor, med hexamethylentetramin i et indifferent organisk opløsningsmiddel, eventuelt under isolering af et mellemprodukt med den almene formel 30 p R^ 0 -C-CH2N4®(CH2)6 β ^ I 111 R1 2Wherein R 1, R 2 and R 3 are as defined above, and X represents chlorine, bromine or iodine, preferably chlorine, with hexamethylenetetramine in an inert organic solvent, optionally while isolating an intermediate of the general formula 30 p R C-CH2N4® (CH2) 6 β ^ I 111 R1 2

DK 155326 BDK 155326 B

i hvilken R1, R2, R3 og X har den ovenfor angivne betydning, og påfølgende ringslutning deraf til den tilsvarende forbindelse med den almene formel I, og denne fremgangsmåde er ejendommelig ved, at man 5 (a) under den direkte gennemførelse af fremgangsmåden (II-»I) eller - i tilfælde af isolering af mellemproduktet med formlen (III) - i trinnet (III->I) og/eller i trinnet (II-»III) arbejder under tilførsel af ammoniak, og at man 10 (b) pr. mol af forbindelsen med formlen (II) anvender hexamethylentetramin.in which R 1, R 2, R 3 and X have the meaning given above, and subsequent cyclization thereof to the corresponding compound of general formula I, and this process is characterized in that 5 (a) during the direct execution of the process (II) - 'I) or - in the case of isolation of the intermediate of formula (III) - in the step (III-> I) and / or in the step (II-' III) working under the supply of ammonia, and that 10 (b) per. moles of the compound of formula (II) use hexamethylenetetramine.

De nævnte alkylgrupper kan være ligekædede eller forgrenede, såsom methyl, ethyl, propyl og butyl. Såfremt R2 betegner alkyl, foretrækkes en methylgruppe. Udtrykket 15 ’’halogen" betegner de fire halogener brom, chlor, fluor og iod, såfremt intet andet er angivet. Hvis R1 betyder halogen, foretrækkes chlor og brom, navnligt chlor. Såfremt R3 betegner o-halogenphenyl, foretrækkes o-chlorphenyl og o-fluor-phenyl, ganske særligt o-fluorphenyl.Said alkyl groups may be straight or branched chain, such as methyl, ethyl, propyl and butyl. If R 2 is alkyl, then a methyl group is preferred. The term 15 '"halogen" means the four halogens bromine, chlorine, fluorine and iodine, unless otherwise indicated. If R1 is halogen, then chlorine and bromine are preferred, especially chlorine. If R3 is o-halogenophenyl, o-chlorophenyl and o are preferred. -fluoro-phenyl, especially o-fluorophenyl.

20 Ved fremgangsmåden ifølge opfindelsen fremstilles der fortrinsvis følgende forbindelser: 7-chlor-l,3-dihydro- 5-phenyl-2H-l,4-benzodiazepin-2-on, 7-chlor-5-(2-chlorphe-nyl)-l,3-dihydro-2H-l,4-benzodiazepin-2-on, 1,3-dihydro-7-nitro-5-phenyl-2H-l,4-benzodiazepin-2-on, 7-chlor-5-(2-flu-25 orphenyl)-l,3-dihydro-2H-l,4-benzodiazepin-2-on, 5-(2-fluor-phenyl) -1,3-dihydro-7-nitro-2H-l, 4-benzodiazepin-2-on, 5-(2-chlorphenyl)-1,3-dihydro-7-nitro-2H-l,4-benzodiazepin-2-on, 7-brom-l,3-dihydro-5-(2-pyridyl)-2H-1,4-benzodiazepin- 2-on samt 1-methyl-derivaterne af disse forbindelser.In the process of the invention, the following compounds are preferably prepared: 7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one, 7-chloro-5- (2-chlorophenyl) -1,3-dihydro-2H-1,4-benzodiazepin-2-one, 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one, 7-chloro-5 - (2-fluorophenyl) -1,3-dihydro-2H-1,4-benzodiazepin-2-one, 5- (2-fluoro-phenyl) -1,3-dihydro-7-nitro-2H - 1,4-Benzodiazepin-2-one, 5- (2-chlorophenyl) -1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one, 7-bromo-1,3-dihydro-2-one 5- (2-pyridyl) -2H-1,4-benzodiazepin-2-one as well as the 1-methyl derivatives of these compounds.

30 Der kendes en fremgangsmåde til fremstilling af ben- zodiazepiner med den almene formel I under anvendelse af en forbindelse med den almene formel II som udgangsmateriale og hexamethylentetramin. Ved denne kendte fremgangsmåde fås der imidlertid ikke særligt gode udbytter, når R2 i udgangs-35 materialet betegner hydrogen; en indgående undersøgelse af syntesen har nemlig afsløret, at den kun er anvendelig til 3A process for the preparation of benzodiazepines of general formula I is known using a compound of general formula II as starting material and hexamethylenetetramine. However, in this known process, very good yields are not obtained when R 2 in the starting material represents hydrogen; an in-depth study of the synthesis has revealed that it is only applicable to 3

DK 155326 BDK 155326 B

fremstilling af forbindelserne med en substituent i 1-stil-lingen. De i 1-stillingen usubstituerede forbindelser lader sig efter den kendte metode ikke fremstille i praktisk udnyttelige mængder; dette står i modsætning til angivelserne 5 på side 1174, spalte 2, andet afsnit i Journal of Heterocyclic Chemistry, 7, 1173 ff (1970), hvor det hævdes, at sådanne forbindelser lader sig fremstille i 70-80%'s udbytte.preparing the compounds with a substituent in the 1 position. The unsubstituted compounds in the 1-position cannot be produced in practically usable quantities by the known method; this contrasts with the statement 5 on page 1174, column 2, second paragraph of the Journal of Heterocyclic Chemistry, 7, 1173 et seq. (1970), where it is claimed that such compounds can be produced in 70-80% yield.

Den kendte metode har således kun meget begrænset anvendelighed, medens man ved fremgangsmåden ifølge den 10 foreliggende opfindelse opnår forbindelserne I i højt udbytte og uafhængigt af udgangsmaterialet. Fremgangsmåden ifølge opfindelsen muliggør således fremstillingen af forskellige, kommercielt vigtige benzodiazepiner ved én og samme metode; ydermere fås forbindelserne i højere udbytter end ved den 15 kendte metode og tillige med større renhed.Thus, the known method has very limited utility, while in the process of the present invention the compounds I are obtained in high yield and independent of the starting material. Thus, the process of the invention enables the preparation of different, commercially important benzodiazepines by one and the same method; moreover, the compounds are obtained in higher yields than by the known method and also with greater purity.

Ved en udførelsesform for opfindelsen, nemlig omsætningen af en forbindelse af formlen II med hexamethylen-tetramin i nærværelse af ammoniak, udføres omsætningen i nærværelse af et vilkårligt, til opfindelsens formål egnet, 20 indifferent organisk opløsningsmiddel. Sådanne egnede, indifferente organiske opløsningsmidler omfatter lavere alka-noler såsom methanol, ethanol og n-butanol, dimethylformamid og lignende indifferente organiske opløsningsmidler samt vandige blandinger deraf, f.éks. vandig ethanol (95%'s) og 25 vandig butanol. Opløsningsmidlet skal vælges således, at udgangsmaterialet er opløseligt deri, og at opløsningsmidlet ikke griber ind i omsætningen. Det foretrækkes at anvende lavere alkanoler såsom methanol og ethanol. Endvidere skal opløsningsmidlet vælges således, at det har den egenskab, 30 at det kan opløse ammoniak, således, at omsætningen kan gennemføres. Temperaturer og tryk er ikke kritiske for en heldig gennemførelse af den her omhandlede fremgangsmåde. Omsætningen udføres dog fortrinsvis ved en temperatur mellem omtrentlig stuetemperatur og omtrentlig tilbagesvalingstem-35 peratur for reaktionsblandingen. Det foretrækkes især at anvende forhøjede temperaturer. Særlig egnet er en temperatur 4In one embodiment of the invention, namely the reaction of a compound of formula II with hexamethylene tetramine in the presence of ammonia, the reaction is carried out in the presence of any inert organic solvent suitable for the purpose of the invention. Such suitable inert organic solvents include lower alkanols such as methanol, ethanol and n-butanol, dimethylformamide and similar inert organic solvents as well as aqueous mixtures thereof, e.g. aqueous ethanol (95%) and aqueous butanol. The solvent must be selected such that the starting material is soluble therein and that the solvent does not interfere with the reaction. It is preferred to use lower alkanols such as methanol and ethanol. Further, the solvent must be selected such that it has the property of dissolving ammonia so that the reaction can be carried out. Temperatures and pressures are not critical to the successful implementation of the process in question. However, the reaction is preferably carried out at a temperature between approximate room temperature and approximate reflux temperature of the reaction mixture. It is particularly preferred to use elevated temperatures. Particularly suitable is a temperature 4

DK 155326 BDK 155326 B

ved reaktionsblandingens omtrentlige tilbagesvalingstemperatur. Endvidere kan reaktionen også udføres under tryk for at forøge ammoniakkoncentrationen i reaktionsblandingen.at the approximate reflux temperature of the reaction mixture. Furthermore, the reaction can also be carried out under pressure to increase the ammonia concentration in the reaction mixture.

Fortrinsvis sættes ammoniakken i sådanne mængder til 5 reaktionsmediet, at det indifferente organiske opløsningsmiddel mættes med ammoniak. Som ovenfor antydet udføres reaktionen fortrinsvis ved reaktionsblandingens tilbagesvalingstemperatur, da der i så tilfælde i almindelighed kræves mindre ammoniak til mætning af et opløsningsmiddel 10 ved forhøjede temperaturer. Til en heldig gennemførelse af omsætningen af en forbindelse med formlen II med hexamethy-lentetramin kræves der sædvanligvis kun en ringe molær mængde ammoniak. Således udvælges der ved den foretrukne udførelsesform et opløsningsmiddel, som har den egenskab, at det 15 opløser udgangsmaterialet, men allerede overmættes med ammoniak ved anvendelse af forholdsvis små molære mængder.Preferably, the ammonia is added in such amounts to the reaction medium that the inert organic solvent is saturated with ammonia. As indicated above, the reaction is preferably carried out at the reflux temperature of the reaction mixture, since then less ammonia is generally required to saturate a solvent 10 at elevated temperatures. For the successful completion of the reaction of a compound of formula II with hexamethylentetramine, only a small molar amount of ammonia is usually required. Thus, in the preferred embodiment, a solvent is selected which has the property of dissolving the starting material but is already superimposed with ammonia using relatively small molar amounts.

Eksempelvis anvendes der ved en foretrukken udførelsesform ethanol. Denne er mættet, når der er ca. 1 molprocent ammoniak til stede. Denne procentangivelse beregnes efter 20 en brøk, hvis numerator er den molære mængde ammoniak, som kræves til overmætning af opløsningsmidlet, og hvis divisor er summen af molære mængder af hexamethylentetramin, forbindelsen med formlen II og i reaktionsblandingen tilstedeværende ammoniak. Opløseligheden af ammoniak i ethvert af de 25 til opfindelsens formål egnede indifferente organiske opløsningsmidler kan let bestemmes ved hjælp af kendte opslagsværker. Med denne bestemmelse kan der også let tilvejebringes det bedst egnede, indifferente organiske opløsningsmiddel.For example, in a preferred embodiment, ethanol is used. This is saturated when there are approx. 1 mole percent of ammonia present. This percentage is calculated after 20 fractions whose numerator is the molar amount of ammonia required for supersaturation of the solvent and whose divisor is the sum of molar amounts of hexamethylenetetramine, the compound of formula II and the ammonia present in the reaction mixture. The solubility of ammonia in any of the inert organic solvents suitable for the invention can be readily determined by known reference works. With this assay, the most suitable inert organic solvent can also be readily obtained.

Som ovenfor antydet bevirker anvendelsen af tryk en forøgelse 30 af ammoniakkoncentrationen i reaktionsmediet ud over den koncentration, som normalt er nødvendig til mætning af det indifferente organiske opløsningsmiddel. Således gennemføres reaktionen i en bestemt udførelsesform under et tryk på ca.As indicated above, the use of pressure causes an increase in the concentration of ammonia in the reaction medium in addition to the concentration normally required for saturation of the inert organic solvent. Thus, the reaction is carried out in a particular embodiment under a pressure of approx.

1-2 atmosfærer. Højere ammoniakkoncentrationer kan let opnås 35 ved, at der anvendes et egnet vandigt, indifferent organisk opløsningsmiddel.1-2 atmospheres. Higher ammonia concentrations can easily be obtained by using a suitable aqueous inert organic solvent.

55

DK 155326 BDK 155326 B

Det iagttages, at der ved gennemførelse af den her omhandlede fremgangsmåde dannes et mellemprodukt med den ovenfor viste formel III. Dette mellemprodukt kan man med eller uden isolering fra det reaktionsmedium, hvori det er 5 dannet, omsætte med ammoniak til den ønskede forbindelse med den almene formel I.It is observed that in carrying out the process of this invention, an intermediate of the formula III shown above is formed. This intermediate can be reacted with or without isolation from the reaction medium in which it is formed with ammonia to the desired compound of the general formula I.

Således kan en forbindelse med formel III, især en sådan, i hvilken R2 betegner alkyl, isoleres fra reaktions-blandingen og behandles med ammoniak, hvorved der fås en 10 tilsvarende forbindelse med formlen I. På den anden side kan man også sætte en forbindelse med formlen II og hexame-thylentetramin til opløsningsmidlet og først tilføre ammoniakken derefter, dvs. uden isolering af forbindelsen med formlen III. I en foretrukken udførelsesform isoleres mel-15 lemproduktet med formlen III ikke, men omsættes med ammoniak uden isolering fra reaktionsmediet. Dette udføres først og fremmest, når R2 betegner hydrogen.Thus, a compound of formula III, especially one in which R 2 represents alkyl, can be isolated from the reaction mixture and treated with ammonia to give a corresponding compound of formula I. On the other hand, a compound of the formula II and hexamethylenetetramine to the solvent and first add the ammonia thereafter, i. without isolating the compound of formula III. In a preferred embodiment, the intermediate of formula III is not isolated but reacted with ammonia without isolation from the reaction medium. This is primarily done when R 2 represents hydrogen.

Man kan også fremstille en forbindelse med formlen III på anden måde end ovenfor beskrevet. Eksempelvis kan 20 man på analog måde, f.eks. som beskrevet i den nævnte artikel i Journal of Heterocyclic Chemistry, sætte en forbindelse med formlen II og hexamethylentetramin under omrøring ved stuetemperatur til et opløsningsmiddel med lavere polaritet, f.eks. acetonitril, og isolere mellemproduktet med formlen 25 III. Den således fremkomne forbindelse med formlen III omsættes med ammoniak efter isolering fra det opløsningsmiddel, hvori den er fremstillet, hvorved der fås en forbindelse med formlen I i godt udbytte og med høj renhed. Således som det er nærliggende for en fagmand, forløber reaktionen mellem 30 en forbindelse med formlen III og ammoniak under de samme reaktionsbetingelser, som ovenfor er beskrevet i forbindelse med fremstillingen af en forbindelse med formlen I ud fra en forbindelse med formel II ud fra hexamethylentetramin og ammoniak. Således kan der til omsætningen af et mellemprodukt 35 med formlen III med ammoniak anvendes de samme reaktionsbetingelser og opløsningsmidler, som ovenfor er nævnt i forbin- 6A compound of formula III may also be prepared by other means than described above. For example, one can analogously, e.g. as described in the said article in the Journal of Heterocyclic Chemistry, adding a compound of formula II and hexamethylenetetramine with stirring at room temperature to a lower polarity solvent, e.g. acetonitrile, and isolate the intermediate of formula 25 III. The compound of formula III thus obtained is reacted with ammonia after isolation from the solvent in which it is prepared to give a compound of formula I in good yield and with high purity. As is apparent to one skilled in the art, the reaction between a compound of formula III and ammonia proceeds under the same reaction conditions described above in the preparation of a compound of formula I from a compound of formula II from hexamethylenetetramine and ammonia. Thus, for the reaction of an intermediate 35 of formula III with ammonia, the same reaction conditions and solvents mentioned above in compound 6 can be used.

DK 155326 BDK 155326 B

delse med fremstillingen af en forbindelse med formlen I, dog med den undtagelse, at der ikke anvendes hexamethylen-tetramin til omsætningen.with the preparation of a compound of formula I, except that hexamethylene tetramine is not used for the reaction.

Som det fremgår klart af det ovenstående, består 5 fremgangsmåden ifølge opfindelsen i, at man sætter ammoniak til det reaktionsmedium, hvori der findes hexamethylente-tramin og en forbindelse med formlen II, henholdsvis et mellemprodukt med formlen III, og at man pr. mol af forbindelsen med formlen II anvender mindst 0,1 mol hexamethylen-10 tetramin. Den måde, på hvilken ammoniakken sættes til reaktionsblandingen, er ikke kritisk. F.eks. kan man sætte hexa-methylentetraminen og ammoniakken til det indifferente organiske opløsningsmiddel og først dernæst tilsætte forbindelsen med formlen II. På den anden side kan man også opløse 15 ammoniakken i et indifferent organisk opløsningsmiddel og dernæst tilsætte en forbindelse med formlen II og hexame-thylentetramin eller mellemproduktet med formlen III til reaktionsblandingen.As is clear from the foregoing, the process of the invention consists in adding ammonia to the reaction medium containing hexamethylenetramine and a compound of formula II and an intermediate of formula III, respectively. moles of the compound of formula II use at least 0.1 mole of hexamethylene tetramine. The way in which the ammonia is added to the reaction mixture is not critical. Eg. For example, the hexa-methylenetetramine and ammonia can be added to the inert organic solvent and only then the compound of formula II is added. On the other hand, one can also dissolve the ammonia in an inert organic solvent and then add a compound of formula II and hexamethylene tetramine or the intermediate of formula III to the reaction mixture.

Som allerede ovenfor nævnt er den måde, på hvilken 20 ammoniakken tilsættes, ikke kritisk. I en foretrukken udførelsesform tilsættes ammoniakken på den måde, at der ledes gasformig ammoniak gennem reaktionsblandingen. Ifølge en i mindre grad foretrukken udførelsesform kan man til reaktionsblandingen tilføre ammoniak også ved hjælp af et am-25 moniak-leverende reagens, f.eks. ammoniumcarbonat, der i opløsningsmiddelmediet, f.eks. ethanol, som opvarmes til tilbagesvaling, sønderdeles til ammoniak. Ved anvendelse af et ammoniak-leverende reagens i stedet for ammoniak selv er udbytterne sædvanligvis ikke så gode.As already mentioned above, the manner in which the ammonia is added is not critical. In a preferred embodiment, the ammonia is added by passing gaseous ammonia through the reaction mixture. According to a less preferred embodiment, ammonia can also be added to the reaction mixture by means of an ammonia-supplying reagent, e.g. ammonium carbonate which in the solvent medium, e.g. ethanol, which is heated to reflux, decomposes to ammonia. When using an ammonia-supplying reagent instead of ammonia itself, the yields are usually not as good.

30 Et særligt bemærkelsesværdigt kendetegn ved den her omhandlede fremgangsmåde består i, at der ikke kræves større molære overskud af hexamethylentetramin til opnåelse af en heldig gennemførelse af fremgangsmåden. Således får man f.eks. allerede ved anvendelse af kun 0,1 mol pr. mol anvendt 35 udgangsmateriale med formlen II den ønskede forbindelse med formel I. Fortrinsvis anvendes der imidlertid ca. 0,5 mol 730 A particularly notable feature of the process at issue here is that no greater molar excess of hexamethylenetetramine is required to achieve a successful implementation of the process. Thus one gets e.g. already using only 0.1 moles per moles of starting material of formula II, the desired compound of formula I. Preferably, however, approx. 0.5 mol 7

DK 155326 BDK 155326 B

hexamethylentetramin pr. mol forbindelse II. Den foreliggende opfindelse frembyder således en yderligere og særlig bemærkelsesværdig fordel, idet den til reaktionerne nødvendige mængde hexamethylentetramin nedsættes til et minimum, hvorfor 5 der som følge heraf kan opnås en formindskelse af slutproduktets fremstillingsomkostninger, uden at der må tages en tilsvarende udbyttenedgang med i købet. På grund af denne bemærkelsesværdige fordel er den her omhandlede fremgangsmåde kommercielt særlig interessant. Der bemærkes, at udbyt-10 terne bliver noget dårligere, når der anvendes mindre end 0,5 mol hexamethylentetramin. Anvendes der imidlertid 0,5 mol hexamethylentetramin, får man de ønskede forbindelser med formlen I i fortrinlige udbytter og i særlig god kvalitet.hexamethylenetetramine per mole of compound II. Thus, the present invention provides a further and particularly noteworthy advantage in that the amount of hexamethylenetetramine required for the reactions is reduced to a minimum, and consequently a reduction in the cost of manufacture of the final product can be obtained without having to take a corresponding yield reduction. Because of this remarkable advantage, the process of the present invention is of particular commercial interest. It is noted that the yields become somewhat inferior when less than 0.5 mole of hexamethylenetetramine is used. However, if 0.5 mole of hexamethylenetetramine is used, the desired compounds of formula I are obtained in excellent yields and in particularly good quality.

15 Ved gennemførelsen af de ovenfor beskrevne fremgangs mådeforanstaltninger, navnlig ved anvendelse af et udgangsmateriale med formlen II, hvori R2 betegner hydrogen, er det blevet iagttaget, at reaktionen mellem hexamethylentetramin og en forbindelse med formlen II forløber under 20 dannelse af formaldehyd. Den i reaktionsblandingen tilstedeværende ammoniak reagerer med det således dannede formaldehyd under nydannelse af hexamethylentetramin. Det er endvidere også blevet fastslået, at de ønskede forbindelser med formlen I også kan fremstilles ved behandling af en 25 forbindelse med formlen II med formaldehyd i nærværelse af overskud af ammoniak.In carrying out the above-described mode of action, in particular using a starting material of formula II wherein R 2 represents hydrogen, it has been observed that the reaction of hexamethylenetetramine with a compound of formula II proceeds during formation of formaldehyde. The ammonia present in the reaction mixture reacts with the formaldehyde thus formed to recreate hexamethylenetetramine. Furthermore, it has also been established that the desired compounds of formula I can also be prepared by treating a compound of formula II with formaldehyde in the presence of excess ammonia.

Ved dette fremgangsmådeaspekt kan der anvendes vandfrit formaldehyd (paraformaldehyd) eller vandig formaldehyd (38%'s formalin). Temperatur og tryk er ikke kritiske for 30 en heldig gennemførelse af dette fremgangsmådeaspekt. Omsætningen udføres imidlertid fortrinsvis ved forhøjet tempertur, f.eks. omtrentlig ved reaktionsblandingens tilbagesvalingstemperatur. Omsætningen sker hensigtsmæssigt i nærværelse af et indifferent organisk opløsningsmiddel. De mange indif-35 ferente organiske opløsningsmidler, der egner sig til opfindelsens formål, omfatter de opløsningsmidler, som ovenforIn this process aspect, anhydrous formaldehyde (paraformaldehyde) or aqueous formaldehyde (38% formalin) can be used. Temperature and pressure are not critical to the successful implementation of this process aspect. However, the reaction is preferably carried out at elevated temperature, e.g. approximately at the reflux temperature of the reaction mixture. The reaction is conveniently carried out in the presence of an inert organic solvent. The many inert organic solvents suitable for the purposes of the invention comprise the solvents mentioned above.

DK 155326 BDK 155326 B

s er nævnt i forbindelse med dannelsen af en forbindelse med formlen I ud fra en forbindelse med formlen II, hexamethy-lentetramin og ammoniak. Således kan der som egnede opløsningsmidler nævnes methanol, ethanol, n-butanol, dimethyl-5 formamid og lignende indifferente organiske opløsningsmidler samt vandige blandinger deraf, f.eks. vandig ethanol eller methanol. Også her bør opløsningsmidlet vælges således, at udgangsmaterialet er opløseligt deri, og at udgangsmaterialet ikke indgriber i reaktionen. Methanol og/eller ethanol fore-10 trækkes.s is mentioned in connection with the formation of a compound of formula I from a compound of formula II, hexamethylentetramine and ammonia. Thus, suitable solvents may be mentioned methanol, ethanol, n-butanol, dimethylformamide and similar inert organic solvents as well as aqueous mixtures thereof, e.g. aqueous ethanol or methanol. Here, too, the solvent should be selected such that the starting material is soluble therein and that the starting material does not interfere with the reaction. Methanol and / or ethanol are preferred.

Det fremgår af det ovenstående, at formaldehydet ved dette fremgangsmådeaspekt reagerer med den ammoniak, der er til stede i molært overskud, under dannelse af hexamethy-lentetramin, hvorved der fås en forbindelse med formlen 15 III, som med eller uden isolering, fortrinsvis uden isolering, omdannes til en forbindelse med formlen I. Mængden og den måde, på hvilken ammoniakken sættes til reaktionsblandingen, er den samme som ovenfor beskrevet i forbindelse med fremstillingen af en forbindelse med formlen I under 20 anvendelse af hexamethylentetramin og ammoniak. Således mættes opløsningsmidlet med ammoniak i en foretrukken udførelsesform, fortrinsvis idet ammoniakken ledes gennem opløsningsmidlet.It is apparent from the foregoing that, in this process aspect, the formaldehyde reacts with the ammonia present in molar excess to form hexamethylene tetramine to give a compound of Formula III, which with or without isolation, preferably without isolation. is converted into a compound of formula I. The amount and manner of ammonia added to the reaction mixture are the same as described above in the preparation of a compound of formula I using hexamethylenetetramine and ammonia. Thus, the solvent is saturated with ammonia in a preferred embodiment, preferably as the ammonia is passed through the solvent.

De følgende udførelseseksempler tjener til nærmere 25 belysning af den her omhandlede fremgangsmåde.The following exemplary embodiments serve to elucidate more fully the process of the present invention.

Eksempel 1 I en 2 liters firhalset kolbe, der er udstyret med omrører, tilbagesvalingskøler og gastilledningsrør til am-30 moniak, anbringes der 600 ml ethanol og 31,7 g hexamethylentetramin. Dernæst ledes der under omrøring ammoniak gennem reaktionsopløsningen, indtil reaktionsmediet er mættet med ammoniak. Den mættede opløsning opvarmes til tilbagesvaling, medens gennemledningen af ammoniak fortsættes. Dernæst til-35 sættes der forsigtigt i løbet af 2 timer 78 g 2-brom-2’-(2-fluorbenzoyl)-4'-nitroacetanilid, idet tilbagesvalingsbetin- 9Example 1 Into a 2 liter four neck flask equipped with stirrer, reflux condenser and gas supply tube for ammonia, place 600 ml of ethanol and 31.7 g of hexamethylenetetramine. Then, with stirring, ammonia is passed through the reaction solution until the reaction medium is saturated with ammonia. The saturated solution is heated to reflux while the passage of ammonia is continued. Next, 2 g of 2-bromo-2 '- (2-fluorobenzoyl) -4'-nitroacetanilide is added cautiously over 2 hours with refluxing reflux.

DK 155326 BDK 155326 B

gelserne igen opretholdes. Reaktionsblandingen opvarmes yderligere i 3 timer til tilbagesvaling og inddampes derpå under formindsket tryk ved 50°C til tørhed. Til remanensen sættes der 300 ml toluen og 0,4 g p-toluensulfonsyre. Den 5 fremkomne reaktionsblanding opvarmes til tilbagesvaling i 1 time. Blandingen afkøles dernæst til ca. 70°C og vaskes med vand. Toluenlaget afkøles dernæst til stuetemperatur, og det krystallinske produkt fraskilles ved filtrering, vaskes med toluen og tørres, hvorved der fås 5-(2-fluorphenyl)-1,3-10 dihydro-7-nitro-2H-l,4-benzodiazepin-2-on med smp. 210-215°C. Udbyttet er 25,5%.the gums are again maintained. The reaction mixture is further heated for 3 hours to reflux and then evaporated under reduced pressure at 50 ° C to dryness. To the residue are added 300 ml of toluene and 0.4 g of p-toluenesulfonic acid. The resulting reaction mixture is heated to reflux for 1 hour. The mixture is then cooled to ca. 70 ° C and washed with water. The toluene layer is then cooled to room temperature and the crystalline product is separated by filtration, washed with toluene and dried to give 5- (2-fluorophenyl) -1,3-10 dihydro-7-nitro-2H-1,4-benzodiazepine 2-on with m.p. 210-215 ° C. The yield is 25.5%.

Eksempel 2 I en 2 liters firhalset kolbe, der er udstyret med 15 røreværk, tilbagesvalingskøler og gastilledningsrør for ammoniak, anbringes der 600 ml ethanol og 31,2 hexamethylen-tetramin. Under omrøring ledes der ammoniak gennem den fremkomne reaktionsopløsning i så lang tid, at ethanolen mættes med ammoniak. Den fremkomne reaktionsblanding opvarmes til 20 tilbagesvaling. Under opretholdelse af tilbagesvalingsbetingelserne og gennemledningen af ammoniak tilsættes der i løbet af et tidsrum på 2 timer forsigtigt 40 g 2-brom-4·-chlor-2'-(2-chlorbenzoyl)-acetanilid. Den således fremkomne reaktionsblanding inddampes derefter til tørhed. Til rema-25 nensen sættes der 300 ml toluen og derefter 0,3 g p-toluen-sulfonsyre. Toluenopløsningen opvarmes til tilbagesvaling. Reaktionsblandingen afkøles til 70°C. Efter afkølingen vaskes den med vand. Toluenekstrakten afkøles til stuetemperatur, og efter afkøling til 10°C skilles det dannede, krystallinske 30 produkt fra ved filtrering, vaskes med toluen og petroleums-ether og tørres natten over under formindsket tryk ved 100°C, hvorved der fås 7-chlor-5-(2-chlorphenyl)-l,3-dihydro-2H- l,4-benzodiazepin-2-on med smp. 200-200,5°C. Udbyttet er 68,3%.Example 2 Into a 2 liter four-necked flask equipped with 15 stirrer, reflux condenser and gas supply tube for ammonia, place 600 ml of ethanol and 31.2 hexamethylene tetramine. With stirring, ammonia is passed through the resulting reaction solution for so long that the ethanol is saturated with ammonia. The resulting reaction mixture is heated to reflux. While maintaining the reflux conditions and passing through ammonia, cautiously 40 g of 2-bromo-4 · -chloro-2 '- (2-chlorobenzoyl) -acetanilide are gently added over a period of 2 hours. The reaction mixture thus obtained is then evaporated to dryness. To the residue is added 300 ml of toluene and then 0.3 g of p-toluene sulfonic acid. The toluene solution is heated to reflux. The reaction mixture is cooled to 70 ° C. After cooling it is washed with water. The toluene extract is cooled to room temperature and after cooling to 10 ° C, the crystalline product formed is separated by filtration, washed with toluene and petroleum ether and dried overnight under reduced pressure at 100 ° C to give 7-chloro-5 - (2-chlorophenyl) -1,3-dihydro-2H-1,4-benzodiazepin-2-one, m.p. 200 to 200.5 ° C. The yield is 68.3%.

1010

DK 155326 BDK 155326 B

Eksempel 3 I en 2 liters firhalset kolbe, der er udstyret med omrører, et gasindledningsrør til ammoniak og tilbagesvalingskøler, anbringes der 600 ml ethanol og 30,4 g hexame-5 thylentetramin. Gennem reaktionsblandingen ledes der ammoniak i så lang tid, at ethanolen overmættes. Reaktionsblandingen opvarmes til tilbagesvaling, og der tilsættes i løbet af 3½ time forsigtigt 40 g 2-brom-2·-(2-chlorbenzoyl)-4'-nitro-acetanilid. Opvarmningen til tilbagesvaling og gennemled-10 ningen af ammoniak gennem reaktionsblandingen fortsættes i de næste 3 timer, hvorefter reaktionsblandingen inddampes til tørhed. Til remanensen sættes der 250 ml toluen og 0,04 g p-toluensulfonsyre. Blandingen opvarmes i 1 time til tilbagesvaling, og toluenfasen afkøles til 70°C. Den dannede 15 opløsning vaskes med vand, og toluenfasen afkøles dernæst til stuetemperatur. Produktet krystalliserer fra reaktionsblandingen. Krystallerne skilles fra ved filtrering, vaskes én gang med toluen og én gang med petroleumsether, hvorved der fås 5-(2-chlorphenyl)-1,3-dihydro-7-nitro-2H-l,4-ben-20 zodiazepin-2-on med smp. 203-204°C. Udbyttet er 62,9%.Example 3 Into a 2 liter four neck flask equipped with a stirrer, a gas introductory tube for ammonia and reflux condenser, place 600 ml of ethanol and 30.4 g of hexamethylene tetramine. Ammonia is passed through the reaction mixture for so long that the ethanol is supersaturated. The reaction mixture is heated to reflux and gently added 40 g of 2-bromo-2 · - (2-chlorobenzoyl) -4'-nitro-acetanilide over 3½ hours. The reflux heating and the passage of ammonia through the reaction mixture is continued for the next 3 hours, after which the reaction mixture is evaporated to dryness. To the residue are added 250 ml of toluene and 0.04 g of p-toluenesulfonic acid. The mixture is heated to reflux for 1 hour and the toluene phase is cooled to 70 ° C. The resulting solution is washed with water and the toluene phase is then cooled to room temperature. The product crystallizes from the reaction mixture. The crystals are separated by filtration, washed once with toluene and once with petroleum ether to give 5- (2-chlorophenyl) -1,3-dihydro-7-nitro-2H-1,4-benzodiaziazepine-2 -on with m.p. 203-204 ° C. The yield is 62.9%.

Eksempel 4 I en 12 liters trehalset kolbe, der er udstyret med køler og et gasindledningsrør for ammoniak, anbringes der 25 7,2 liter ethanol og 470,4 g hexamethylentetramin. Under omrøring ledes ammoniak gennem reaktionsopløsningen, indtil denne er overmættet. Under opvarmning til tilbagesvaling tilsættes der forsigtigt i løbet af 4 timer 480 g 2-chlor-acetamido-5-chlorbenzophenon. Den fremkomne reaktionsblanding 30 opvarmes i yderligere 2 timer til tilbagesvaling, idet også gennemledningen af ammoniak fortsættes. Den fremkomne reaktionsblanding henstilles dernæst natten over og inddampes derpå til tørhed under formindsket tryk. Til remanensen sættes der 2,4 liter toluen, og den fremkomne reaktionsblan-35 ding opvarmes til tilbagesvaling. Derpå tilsættes der 0,5 g p-toluensulfonsyre, og opvarmningen til tilbagesvaling fort- 11Example 4 Into a 12 liter three-neck flask equipped with a cooler and an ammonia gas inlet tube are charged 7.2 liters of ethanol and 470.4 g of hexamethylenetetramine. With stirring, ammonia is passed through the reaction solution until it is supersaturated. During reflux heating, 480 g of 2-chloro-acetamido-5-chlorobenzophenone is gently added over 4 hours. The resulting reaction mixture is heated for an additional 2 hours to reflux, as well as the passage of ammonia is continued. The resulting reaction mixture is then left overnight and then evaporated to dryness under reduced pressure. 2.4 liters of toluene are added to the residue and the resulting reaction mixture is heated to reflux. Then 0.5 g of p-toluenesulfonic acid is added and the reflux heating is continued

DK 155326 BDK 155326 B

sættes 1 time. Efter afkøling af reaktionsblandingen til 70°C tilsættes der 1,5 liter varmt vand. Produktet, der udfældes ved afkøling til 20eC, skilles fra ved filtrering, vaskes og tørres under formindsket tryk, hvorved der fås 7-5 chlor-1,3-dihydro-5-phenyl-2H-l,4-benzodiazepin-2-on med smp. 213-214"C. Udbyttet er 80,3%.set for 1 hour. After cooling the reaction mixture to 70 ° C, 1.5 liters of hot water are added. The product precipitated by cooling to 20 ° C is filtered off, washed and dried under reduced pressure to give 7-5 chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one with m.p. 213-214 ° C. The yield is 80.3%.

På analog måde som ovenfor beskrevet kan der fremstilles 2-brom-l,3-dihydro-5-(2-pyridyl)-2H-1,4-benzodiazepin- 2-on med smp. 225-235°C ud fra forbindelsen 2-(2-chloracet-10 amido-5-brombenzoyl)-pyridin.By analogy as described above, 2-bromo-1,3-dihydro-5- (2-pyridyl) -2H-1,4-benzodiazepin-2-one can be prepared with m.p. 225-235 ° C from the compound 2- (2-chloroacet-10-amido-5-bromobenzoyl) -pyridine.

Eksempel 5Example 5

En 12 liters trehalset kolbe, der er udstyret med et tætnet røreværk, tilbagesvalingskøler og et gasindledningsrør 15 for ammoniak, chargeres med 7,2 liter ethanol. Alkoholen opvarmes under omrøring på et dampbad til tilbagesvaling. Opløsningsmidlet mættes dernæst med ammoniak til en koncentration på ca. 0,6-0,7 vægtprocent. Efter fjernelse af varmebadet tilsættes der 493 g hexamethylentetramin. Op-20 varmningen fortsættes på ny, og der tilsættes langsomt og i små portioner 480 g 2-chloracetamido-5-chlorbenzophenon. Ammoniakken ledes stadig gennem den til tilbagesvaling opvarmede opløsning. Tilsætningen af chloracetamidoforbindelsen varer ca. 3-4 timer. Efter afsluttet tilsætning opvarmes 25 reaktionsblandingen yderligere i 2 timer til tilbagesvaling. Gennemledningen af ammoniakstrømmen afbrydes, og alkoholen fjernes ved vakuumdestillation.A 12-liter three-neck flask equipped with a sealed stirrer, reflux condenser and a gas inlet 15 for ammonia is charged with 7.2 liters of ethanol. The alcohol is heated under stirring in a reflux steam bath. The solvent is then saturated with ammonia to a concentration of approx. 0.6-0.7% by weight. After removing the heat bath, 493 g of hexamethylenetetramine are added. The heating is resumed and 480 g of 2-chloroacetamido-5-chlorobenzophenone are added slowly and in small portions. The ammonia is still passed through the refluxed solution. The addition of the chloroacetamido compound lasts approx. 3-4 hours. After completion of the addition, the reaction mixture is further heated for 2 hours to reflux. The flow of ammonia flow is interrupted and the alcohol removed by vacuum distillation.

Remanensen opslæmmes i 2,4 liter toluen og opvarmes til tilbagesvaling. Ved tilbagesvalingstemperatur tilsættes 30 der to gange 0,5 g p-toluensulfonsyre i løbet af 15 minutter.The residue is slurried in 2.4 liters of toluene and heated to reflux. At reflux temperature, 0.5 g of p-toluenesulfonic acid is added twice over 15 minutes.

Der udskilles en ringe mængde vand (ca. 1-2 ml). Krystal-lisatet afkøles derefter til 70°C, og den vandopløselige andel opløses ved tilsætning af 1,5 liter varmt vand (70°C).A small amount of water (about 1-2 ml) is excreted. The crystal lysate is then cooled to 70 ° C and the water-soluble fraction dissolved by the addition of 1.5 liters of hot water (70 ° C).

Den heterogene blanding omrøres natten over, hvorved den 35 afkøles til stuetemperatur. Det udskilte produkt skilles fra ved filtrering, og det vaskes én gang med 250 ml koldt 12The heterogeneous mixture is stirred overnight, allowing it to cool to room temperature. The separated product is separated by filtration and washed once with 250 ml of cold 12

DK 155326 BDK 155326 B

vand og én gang med 250 ml kold toluen (o°C). Produktet tørres derefter til konstant vægt ved 80"C, hvorved der fås 7-chlor-l,3-dihydro-5-phenyl-2H-l,4-benzodiazepin-2-on med smp. 213-214'C. Udbyttet er 80,7%.water and once with 250 ml of cold toluene (o ° C). The product is then dried to constant weight at 80 ° C to give 7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one, mp 213-214 ° C. 80.7%.

55

Eksempel 6 I en 2 liters firhalset kolbe, der er udstyret med et røreværk, tilbagesvalingskøler og et gasindledningsrør til ammoniak, anbringes der 600 ml ethanol og 37,9 g hexa-10 methyentetramin under omrøring. Derefter ledes der ammoniak gennem den fremkomne reaktionsopløsning under opvarmning og omrøring, indtil reaktionsblandingen har nået tilbagesvalingstemperaturen. Dernæst sættes der forsigtigt 40 g 2-chloracetamido-5-nitro-benzophenon til den kogende opløsning.Example 6 Into a 2 liter four neck flask equipped with a stirrer, reflux condenser and a gas introductory tube for ammonia, place 600 ml of ethanol and 37.9 g of hexa-methylene tetramine under stirring. Then ammonia is passed through the resulting reaction solution with heating and stirring until the reaction mixture has reached the reflux temperature. Next, 40 g of 2-chloroacetamido-5-nitro-benzophenone are carefully added to the boiling solution.

15 Ammoniak ledes til stadighed gennem reaktionsblandingen, medens man vedbliver med opvarmningen til tilbagesvaling i yderligere 3 timer. Den fremkomne opløsning afkøles og inddampes til tørhed ved 50“C. Remanensen opløses i 300 ml toluen, der tilsættes 0,3 g p-toluensulfonsyre, og den frem-20 komne reaktionsopløsning opvarmes til tilbagesvaling i 1 time. Dernæst afkøles reaktionsblandignen til stuetemperatur, og det udskilte materiale skilles fra ved filtrering, vaskes med vand og tørres. Remanensen opløses i 435 1 methy-lenchlorid og filtreres derpå gennem Hyflo. Efter tilsætning 25 af 90 ml 3 N salpetersyre til filtratet udskilles der krystaller. Disse skilles fra ved filtrering, vaskes med methy-lenchlorid og tørres i 15 minutter. Krystallerne sættes under omrøring til 1 liter vand. Der tilsættes dernæst forsigtigt ammoniumhydroxidopløsning, indtil pH-værdien har 30 nået 8. Efter en halv times omrøring af den fremkomne reaktionsblanding skilles de udskilte krystaller fra ved filtrering, vaskes med koldt vand og tørres i 8 timer ved 80°C, hvorved der fås l,3-dihydro-7-nitro-5-phenyl-2H-l,4-ben-zodiazepin-2-on med smp. 217-219°C. Udbyttet er 27,2%.Ammonia is constantly passed through the reaction mixture while continuing to reflux for an additional 3 hours. The resulting solution is cooled and evaporated to dryness at 50 ° C. The residue is dissolved in 300 ml of toluene, 0.3 g of p-toluenesulfonic acid is added, and the resulting reaction solution is heated to reflux for 1 hour. Next, the reaction mixture is cooled to room temperature and the separated material is separated by filtration, washed with water and dried. The residue is dissolved in 435 L of methylene chloride and then filtered through Hyflo. After adding 25 ml of 90 ml of 3 N nitric acid to the filtrate, crystals are separated. These are separated by filtration, washed with methylene chloride and dried for 15 minutes. The crystals are stirred into 1 liter of water. Then ammonium hydroxide solution is gently added until the pH has reached 8. After half an hour of stirring the resulting reaction mixture, the separated crystals are separated by filtration, washed with cold water and dried for 8 hours at 80 ° C to give 1 , 3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one, m.p. 217-219 ° C. The yield is 27.2%.

1313

DK 155326 BDK 155326 B

Eksempel 7Example 7

Til 1350 ml ethanol sættes der 90 g 2-chloracetamido- 5-chlorbenzophenon og 92,5 g hexamethylentetramin. Under tryk ledes ammoniak gennem den fremkomne reaktionsblanding, 5 og sidstnævnte opvarmes til tilbagesvaling og inddampes dernæst til tørhed under formindsket tryk. Remanensen udrives dernæst to gange med 250 ml varmt vand. Den vandige fase dekanteres fra, og den krystallinske remanens opvarmes på et dampbad i 30 minutter i 250 ml toluen og afkøles dernæst 10 til stuetemperatur. De dannede krystaller skilles fra ved filtrering, vaskes to gange med 25 ml toluen og 25 ml petro-leumsether og tørres derefter til konstant vægt, hvorved der fås 7-chlor-l,3-dihydro-5-phenyl-2H-l,4-benzodiazepin- 2-on med smp. 213-215°C. Udbyttet er 78%.To 1350 ml of ethanol are added 90 g of 2-chloroacetamido-5-chlorobenzophenone and 92.5 g of hexamethylenetetramine. Under pressure, ammonia is passed through the resulting reaction mixture, and the latter is heated to reflux and then evaporated to dryness under reduced pressure. The residue is then rinsed twice with 250 ml of warm water. The aqueous phase is decanted and the crystalline residue is heated on a steam bath for 30 minutes in 250 ml of toluene and then cooled to room temperature 10. The crystals formed are separated by filtration, washed twice with 25 ml of toluene and 25 ml of petroleum ether and then dried to constant weight to give 7-chloro-1,3-dihydro-5-phenyl-2H-1,4 -benzodiazepine-2-one with m.p. 213-215 ° C. The yield is 78%.

1515

Eksempel 8 13,5 liter 95%'s ethanol, 900 g 2-chloracetamido-5-chlorbenzophenon og 925 g hexamethylentetramin anbringes under omrøring i en trykbeholder. Under omrøring mættes 20 reaktionsblandingen med ammoniak. Ammoniaktilførslen fjernes, og den fremkomne reaktionsblanding opvarmes i 3 timer til 70-80eC. Efter afkøling og afdampning af ammoniakken overføres reaktionsblandingen fra trykbeholderen til en destillationsbeholder. Blandingen inddampes på dampbad under for-25 mindsket tryk til tørhed. Til remanensen sættes der 2\ liter toluen og 5 g p-toluensulfonsyre, og den fremkomne blanding opvarmes til tilbagesvaling. Ca. 5 ml vand, der er blevet dannet, fjernes ved azeotropisk destillation. Efter afkøling til 70°C tilsættes der 3 liter vand med en temperatur på 30 70°C. Det således dannede krystallisat afkøles til 10-15°c i 1 time. Efter frafiltrering, vaskning af produktet med to gange 250 ml vand og én gang 250 ml kold (10°C) toluen og tørring til konstant vægt fås der 7-chlor-l,3-dihydro-5-phenyl-2H-l,4-benzodiazepin-2-on med smp. 211-213,5°C. Ud-35 byttet er 66%.Example 8 13.5 liters of 95% ethanol, 900 g of 2-chloroacetamido-5-chlorobenzophenone and 925 g of hexamethylenetetramine are placed under stirring in a pressure vessel. With stirring, the reaction mixture is saturated with ammonia. The ammonia feed is removed and the resulting reaction mixture is heated to 70-80 ° C for 3 hours. After cooling and evaporating the ammonia, the reaction mixture is transferred from the pressure vessel to a distillation vessel. The mixture is evaporated on a steam bath under reduced pressure to dryness. To the residue are added 2 µl of toluene and 5 g of p-toluenesulfonic acid, and the resulting mixture is heated to reflux. Ca. 5 ml of water formed is removed by azeotropic distillation. After cooling to 70 ° C, 3 liters of water with a temperature of 30 70 ° C are added. The crystalline thus formed is cooled to 10-15 ° C for 1 hour. After filtration, washing the product with twice 250 ml of water and once 250 ml of cold (10 ° C) toluene and drying to constant weight, 7-chloro-1,3-dihydro-5-phenyl-2H-1,4 is obtained. -benzodiazepine-2-one with m.p. 211 to 213.5 ° C. The yield is 66%.

1414

DK 155326 BDK 155326 B

Eksempel 9Example 9

En blanding af 17,5 g hexamethylentetramin (0,125 mol), 135,5 ml methanol og 80,5 g 2-(2-chlor-N-methylacet-amido)-5-chlorbenzophenon (0,25 mol) mættes med ammoniak.A mixture of 17.5 g of hexamethylenetetramine (0.125 mol), 135.5 ml of methanol and 80.5 g of 2- (2-chloro-N-methylacetamido) -5-chlorobenzophenone (0.25 mol) are saturated with ammonia.

5 Under omrøring opvarmes reaktionsblandingen langsomt til tilbagesvalingstemperatur, idet der gennem blandingen ledes en stadig strøm af ammoniak. Under reaktionen dannes forbindelsen 0 10 -°/chA®(CH2)6 c1® 15While stirring, the reaction mixture is slowly heated to reflux temperature, passing through the mixture a steady stream of ammonia. During the reaction, the compound 010 - ° / chA® (CH2) 6 c1® 15 is formed

Dette mellemprodukt isoleres ikke. Reaktionsblandingen opvarmes til tilbagesvaling i 6 timer, hvorefter ammoniakstrømmen afbrydes, og opløsningsmidlet fjernes under formindsket tryk. Remanensen optages i en blanding af 500 ml 20 toluen og 500 ml varmt vand. Toluenfasen skilles fra under omrøring, og dernæst tilsættes der 169 ml 3 N salpetersyre.This intermediate is not isolated. The reaction mixture is heated to reflux for 6 hours, after which the ammonia stream is discontinued and the solvent is removed under reduced pressure. The residue is taken up in a mixture of 500 ml of 20 toluene and 500 ml of hot water. The toluene phase is separated off with stirring and then 169 ml of 3 N nitric acid is added.

De dannede krystaller skilles fra ved filtrering, vaskes med 50 ml toluen og optages påny i en blanding af 250 ml toluen og 250 ml vand. Der tilsættes 30 ml koncentreret 25 ammoniak (pH = 8). Toluenfasen skilles fra, vaskes med 250 ml vand, og dernæst inddampes den under formindsket tryk til tørhed, hvorved der fås 7-chlor-l-methyl-l,3-dihydro-5-phe-nyl-2H-l,4-benzodiazepin-2-on med smp. 125-127°C. Udbyttet er 96,1%.The crystals formed are separated by filtration, washed with 50 ml of toluene and taken up again in a mixture of 250 ml of toluene and 250 ml of water. Add 30 ml of concentrated 25 ammonia (pH = 8). The toluene phase is separated, washed with 250 ml of water and then evaporated to dryness under reduced pressure to give 7-chloro-1-methyl-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepine -2-on with m.p. 125-127 ° C. The yield is 96.1%.

3030

Eksempel 10Example 10

En blanding af 600 ml ethanol og 39,1 g hexamethylentetramin (0,279 mol) mættes under omrøring med ammoniak. Medens man stadig leder ammoniak gennem blandingen, opvarmes 35 denne langsomt til tilbagesvaling. Over et tidsrum på 4½ time tilsættes der i portioner 40 g 2-(2-chlor-N-methylacet- 15A mixture of 600 ml of ethanol and 39.1 g of hexamethylenetetramine (0.279 mol) is saturated with ammonia. While still ammonia is passed through the mixture, it is slowly heated to reflux. Over a period of 4½ hours, 40 g of 2- (2-chloro-N-methyl acetate) are added in portions.

DK 155326 BDK 155326 B

amido)-5-chlorbenzophenon (0,124 mol) under dannelse af en forbindelse med formlen ?h3 s 5 -C-CHA+ (CH2)6 Cl" 10 ^—amido) -5-chlorobenzophenone (0.124 mol) to give a compound of formula H3 s 5 -C-CHA + (CH2) 6 Cl

Uden isolering af dette mellemprodukt fortsættes opvarmningen til tilbagesvaling i yderligere 2 timer. Reaktionsblandingen inddampes derefter til tørhed under formindsket tryk ved 50'C. Remanensen omrøres med 250 ml toluen og opvarmes til 15 tilbagesvaling. Dernæst tilsættes der to portioner p-tolu-ensulfonsyre, og opvarmningen til tilbagesvaling fortsættes i 1 time. Efter afkøling til 70“C vaskes toluenopløsningen med varmt vand til fjernelse af de opløselige salte og inddampes til tørhed under formindsket tryk. Remanensen opløses 20 i varm ethanol (111 mol), og opløsningen afkøles til -10°C i 1 time. Den således fremkomne, krystallinske 7-chlor-l,3-dihydro-l-methyl-5-phenyl-2H-l,4-benzodiazepin-2-on isoleres i en mængde på 29 g og har smp. 129-131°C. Inddampning af moderluden til ca. 50% giver yderligere 2 g slutprodukt med 25 smp. 127 °C.Without isolation of this intermediate, the reflux heating is continued for an additional 2 hours. The reaction mixture is then evaporated to dryness under reduced pressure at 50 ° C. The residue is stirred with 250 ml of toluene and heated to reflux. Next, two portions of p-toluene sulfonic acid are added and heating to reflux is continued for 1 hour. After cooling to 70 ° C, the toluene solution is washed with warm water to remove the soluble salts and evaporated to dryness under reduced pressure. The residue is dissolved in hot ethanol (111 mol) and the solution is cooled to -10 ° C for 1 hour. The crystalline 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one thus obtained is isolated in an amount of 29 g and has m.p. 129-131 ° C. Evaporation of the mother liquor to approx. 50% gives an additional 2 g of final product with 25 m.p. 127 ° C.

Eksempel 11Example 11

En blanding af 1100 ml ethanol, 70,0 g hexamethylen-tetramin (0,5 mol), 58 ml 26%·s ammoniumhydroxidopløsning 30 og 308,2 g 2-chloracetamido-5-chlorbenzophenon (1,0 mol) opvarmes langsomt til tilbagesvaling under omrøring og gen-nemledning af ammoniak. Opvarmningen til tilbagesvaling fortsættes i 5 timer, hvorefter ammoniakstrømmen afbrydes, og reaktionsblandingen inddampes til tørhed under formindsket 35 tryk. Remanensen opvarmes til tilbagesvaling i 30 minutter i en blanding af 500 ml toluen og 500 ml vand og afkøles 16A mixture of 1100 ml of ethanol, 70.0 g of hexamethylene tetramine (0.5 mole), 58 ml of 26% ammonium hydroxide solution 30 and 308.2 g of 2-chloroacetamido-5-chlorobenzophenone (1.0 mole) is slowly heated to reflux while stirring and passing ammonia. The refluxing is continued for 5 hours, after which the ammonia flow is stopped and the reaction mixture is evaporated to dryness under reduced pressure. The residue is heated to reflux for 30 minutes in a mixture of 500 ml of toluene and 500 ml of water and cooled 16

DK 155326 BDK 155326 B

dernæst langsomt til stuetemperatur. De udskilte krystaller skilles fra ved filtrering, vaskes med 100 ml toluen og to gange med 250 ml varmt vand, hvorefter de tørres til konstant vægt. Den således fremkomne 7-chlor-l,3-dihydro-5-phenyl-5 2H-l,4-benzodiazepin-2-on smelter ved 210°C. Udbyttet er 83,5%.then slowly to room temperature. The separated crystals are separated by filtration, washed with 100 ml of toluene and twice with 250 ml of hot water, and then dried to constant weight. The thus-obtained 7-chloro-1,3-dihydro-5-phenyl-5H-1,4-benzodiazepin-2-one melts at 210 ° C. The yield is 83.5%.

Eksempel 12Example 12

En blanding af 1100 ml ethanol, 35 g hexamethylen-10 tetramin (0,25 mol), 58 ml 26%'s ammoniumhydroxidopløsning og 308,2 g 2-chlor-acetamido-5-chlorbenzophenon (1,0 mol) omsættes som beskrevet i eksempel 11 med den undtagelse, at reaktionsblandingen opvarmes til 7 timer under tilbagesvaling i stedet for i 5 timer. Reaktionsproduktet, nemlig 7-chlor-15 l,3-dihydro-5-phenyl-2H-l,4-benzodiazepin-2-on isoleres som beskrevet i eksempel 11 og smelter ved 208,5-209eC. Udbyttet er 81,6%.A mixture of 1100 ml of ethanol, 35 g of hexamethylene-tetramine (0.25 mol), 58 ml of 26% ammonium hydroxide solution and 308.2 g of 2-chloro-acetamido-5-chlorobenzophenone (1.0 mol) is reacted as described. in Example 11, with the exception that the reaction mixture is heated to reflux for 7 hours instead of 5 hours. The reaction product, namely 7-chloro-15,1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one is isolated as described in Example 11 and melts at 208.5-209 ° C. The yield is 81.6%.

Eksempel 13 20 En blanding af 550 ml methanol, 14,1 g hexamethylen- tetramin (0,1 mol) og 308,2 g 2-chloracetamido-5-chlorben-zophenon mættes under omrøring ved stuetemperatur med ammoniak. Blandingen opvarmes langsomt til tilbagesvaling under stadig gennemledning af ammoniak. Opvarmningen til 25 tilbagesvaling fortsættes i 24 timer, hvorefter ammoniakstrømmen fjernes, og det fremkomne krystallisat afkøles til stuetemperatur. Produktet skilles fra ved filtrering, vaskes med 2 gange 125 ml methanol og 4 gange 500 ml varmt vand og tørres, hvorved der fås 7-chlor-l,3-dihydro-5-phenyl-2H-30 l,4-benzodiazepin-2-on med smp. 213-215eC. Udbyttet er 62,3%.Example 13 A mixture of 550 ml of methanol, 14.1 g of hexamethylene tetramine (0.1 mole) and 308.2 g of 2-chloroacetamido-5-chlorobenzophenone are saturated with stirring at room temperature with ammonia. The mixture is slowly heated to reflux while still passing through ammonia. The refluxing is continued for 24 hours, after which the ammonia stream is removed and the resulting crystalline is cooled to room temperature. The product is separated by filtration, washed with 2 times 125 ml of methanol and 4 times 500 ml of hot water and dried to give 7-chloro-1,3-dihydro-5-phenyl-2H-30,4-benzodiazepine-2 -on with m.p. 213-215eC. The yield is 62.3%.

Eksempel 14Example 14

En blanding af 300 ml ethanol og 20 g hexamethylen-tetramin (0,143 mol) mættes med ammoniak under omrøring og 35 opvarmning til tilbagesvaling. 18,1 g 2-chloracetamidoben-zophenon (0,066 mol) tilsættes i små portioner i løbet af 17A mixture of 300 ml of ethanol and 20 g of hexamethylene tetramine (0.143 mol) is saturated with ammonia with stirring and reflux heating. 18.1 g of 2-chloroacetamidobenzophenone (0.066 mol) is added in small portions over 17

DK 155326 BDK 155326 B

3-4 timer, medens en stadig strøm af ammoniak ledes gennem reaktionsblandingen. Efter endt tilsætning af 2-chloracet-amidobenzophenon fortsættes opvarmningen til tilbagesvaling i 3 timer. Ammoniakstrømmen afbrydes, og ethanolen fjernes 5 ved destillation under formindsket tryk. Den således fremkomne remanens optages i 200 ml chloroform og vaskes med 100 ml vand ved en temperatur på 50°C. Chloroformfasen inddampes til tørhed ved 308C, og den olieagtige remanens krystalliseres fra 100 ml toluen, hvorved der fås 1,3-dihydro-10 5-phenyl-2H-1,4-benzodiazepin-2-on med smp. 184-186°C. Ud byttet er 86%.3-4 hours while a steady stream of ammonia is passed through the reaction mixture. After the addition of 2-chloroacetamidobenzophenone, the heating is continued at reflux for 3 hours. The ammonia stream is stopped and the ethanol is removed by distillation under reduced pressure. The residue thus obtained is taken up in 200 ml of chloroform and washed with 100 ml of water at a temperature of 50 ° C. The chloroform phase is evaporated to dryness at 308 C and the oily residue is crystallized from 100 ml of toluene to give 1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one, m.p. 184-186 ° C. Out the exchange is 86%.

Eksempel 15Example 15

En blanding af 275 ml methanol og 154,2 g 2-chlor-15 acetamido-5-chlorbenzophenon (0,5 mol) opvarmes til tilbagesvaling under stadig gennemledning af ammoniak. Ved tilbagesvalingstemperaturen tilsættes der 237 ml 37%'s formaldehydopløsning i løbet af ca. 40 minutter. Reaktionsblandingen opvarmes dernæst til tilbagesvaling i 5 timer. Gen-20 nemledningen af ammoniakken afbrydes, og krystallisatet afkøles til stuetemperatur, filtreres, vaskes med to gange 125 ml methanol og fire gange 500 ml varmt vand og tørres, hvorved der fås 7-chlor-l,3-dihydro-5-phenyl-2H-l,4-ben-zodiazepin-2-on med smp. 211,5-214,58C. Udbyttet er 77,3%.A mixture of 275 ml of methanol and 154.2 g of 2-chloro-15-acetamido-5-chlorobenzophenone (0.5 mol) is heated to reflux while still passing through ammonia. At reflux temperature, 237 ml of 37% formaldehyde solution is added over approx. 40 minutes. The reaction mixture is then heated to reflux for 5 hours. The lead-through of the ammonia is quenched and the crystalline is cooled to room temperature, filtered, washed with twice 125 ml of methanol and four times 500 ml of warm water and dried to give 7-chloro-1,3-dihydro-5-phenyl 2H-1,4-benzodiazepin-2-one with m.p. 211,5-214,58C. The yield is 77.3%.

2525

Eksempel 16Example 16

En blanding af 147,2 g paraformaldehyd og 55o ml methanol opvarmes til tilbagesvaling under omrøring og stadig gennemledning af ammoniak. Efter afkøling af det således 30 fremkomne krystallisat af hexamethylentetramin til stuetemperatur tilsættes portionsvis 308,2 g 2-chloracetamido-5-chlorbenzophenon (1,0 mol). Under gennemledning af ammoniak opvarmes reaktionsblandingen til tilbagesvaling i 10 timer. Gennemledningen af ammoniak afbrydes, og reaktionsblandingen 35 afkøles til stuetemperatur, filtreres, vaskes med to gange 125 ml methanol og fire gange 500 ml varmt vand og tørres, 18A mixture of 147.2 g of paraformaldehyde and 55o ml of methanol is heated to reflux with stirring and still passing through ammonia. After cooling the thus obtained crystallize hexamethylenetetramine to room temperature, 308.2 g of 2-chloroacetamido-5-chlorobenzophenone (1.0 mole) are added portionwise. Under the course of ammonia, the reaction mixture is heated to reflux for 10 hours. The ammonia pass-through is quenched and the reaction mixture is cooled to room temperature, filtered, washed twice with 125 ml of methanol and four times 500 ml of warm water and dried.

DK 155326 BDK 155326 B

hvorved der fås 7-chlor-l,3-dihydro-5-phenyl-2H-l,4-ben-zodiazepin-2-on med smp. 212,5-215“C. Udbyttet er 81,4%.to give 7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one, m.p. 212.5 to 215 "C. The yield is 81.4%.

Eksempel 17 5 I en beholder, der er udstyret med røreværk, tilba gesvalingskøler og gastilledningsrør for ammoniak samt en anordning til af dekantering, anbringes der 200 g paraformaldehyd (91%·s fnug) og 575 ml methanol, hvorefter der ledes gasformig ammoniak gennem blandingen. Der tilsættes dernæst 10 273,7 g 2-chloracetamidobenzophenon. Under gennemledning af en langsom, kontinuerlig ammoniakstrøm opvarmes blandingen til tilbagesvaling i 5 timer. Det fremkomne krystallisat destilleres til tilbagevinding af methanol. Dernæst sættes der 350 ml toluen til den krystallinsk remanens, og det 15 endnu tilstedeværende vand fjernes ved azeotrop destillation. Dernæst filtreres den varme toluenopløsning, og filtratet afkøles til krystallisation, hvorefter der kan isoleres 1,3-dihydro-5-phenyl-2H-l,4-benzodiazepin-2-on med smp. 180-181°C (ikke korrigeret). Udbyttet er 84,7%.Example 17 5 In a container equipped with stirrer, reflux condenser and gas supply tube for ammonia and a decanting device, 200 g of paraformaldehyde (91% s liquor) and 575 ml of methanol are charged and gaseous ammonia is passed through the mixture. . 10 273.7 g of 2-chloroacetamidobenzophenone are then added. Undergoing slow, continuous ammonia flow, the mixture is heated to reflux for 5 hours. The resulting crystallate is distilled to recover methanol. Next, 350 ml of toluene is added to the crystalline residue and the water still present is removed by azeotropic distillation. Next, the hot toluene solution is filtered and the filtrate is cooled to crystallize, after which 1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one can be isolated with m.p. 180-181 ° C (not corrected). The yield is 84.7%.

2020

Eksempel 18 I en beholder, der er udstyret med røreværk, tilbagesvalingskøler og et gastilledningsrør for ammoniak, anbringes der ved stuetemperatur 147,2 g paraf ormaldehyd (91%'s 25 fnug), 550 ml methanol og 326,2 g 2-chloracetamido-5-chlor-2'-fluorbenzophenon. Blandingen omrøres, og der ledes ammoniak under overfladen. Dernæst opvarmes reaktionsblandingen til tilbagesvaling under stadig gennemledning af ammoniakgas i 10 timer. Derefter afkøles der til stuetempera-30 tur, og det krystallinske produkt skilles fra ved filtrering. Produktet vaskes med to gange 125 ml kold methanol (-10°C) og fire gange 500 ml varmt vand (60°C). Efter tørring fås der 7-chlor-5-(2-fluorphenyl)-1,3-dihydro-2H-l,4-benzodiaze-pin-2-on med smp. 205,5-207°C (ikke korrigeret). Udbyttet 35 er 71%.Example 18 In a container equipped with a stirrer, reflux condenser and a gas supply tube for ammonia, at room temperature 147.2 g of paraformaldehyde (91% 25 lb), 550 ml of methanol and 326.2 g of 2-chloroacetamido acid are charged. 5-chloro-2'-fluorobenzophenone. The mixture is stirred and ammonia is passed beneath the surface. Next, the reaction mixture is heated to reflux while still passing ammonia gas for 10 hours. Then, it is cooled to room temperature and the crystalline product is separated by filtration. The product is washed twice with 125 ml of cold methanol (-10 ° C) and four times with 500 ml of hot water (60 ° C). After drying, 7-chloro-5- (2-fluorophenyl) -1,3-dihydro-2H-1,4-benzodiaze-pin-2-one is obtained, m.p. 205.5-207 ° C (not corrected). Yield 35 is 71%.

1919

DK 155326 BDK 155326 B

Eksempel 19 I en 5 liters trehalset kolbe, der er udstyret med røreværk og calciumchlorid-tørrerør, anbringes der 250 g 2-chlor-acetamido-5-chlorbenzophenon og 122,5 g hexamethylen-5 tetramin samt 2,5 liter acetonitril. Blandingen omrøres ved stuetemperatur ved 72 timer, idet begge udgangsmaterialer går i opløsning. Reaktionsproduktet med formlen H 0 —ccKgif,© (ch2)6 ci© 10 ^CXc=o 15 udkrystalliserer derefter, filtreres, vaskes med en ringe mængde frisk opløsningsmiddel og tørres, hvorved man får produktet med smp. 169-170°C.Example 19 Into a 5 liter three neck flask equipped with agitator and calcium chloride drying tube are placed 250 g of 2-chloro-acetamido-5-chlorobenzophenone and 122.5 g of hexamethylene-tetramine and 2.5 liters of acetonitrile. The mixture is stirred at room temperature for 72 hours, dissolving both starting materials. The reaction product of the formula H0 - ccgif, © (ch2) 6 ci © 10 ^ CXc = o is then crystallized, filtered, washed with a small amount of fresh solvent and dried to give the product with m.p. 169-170 ° C.

89,7 g af det således fremkomne produkt opløses i 20 ethanolisk ammoniak. Under stadig gennemledning af gasformig ammoniak opvarmes den således fremkomne blanding i 5 timer til tilbagesvaling, hvorved der fås 7-chlor-l,3-dihydro-5-phenyl-2H-l,4-benzodiazepin-2-on, som isoleres ved kendte metoder. Smp. 212-214°C. Udbyttet er 79,2%.89.7 g of the product thus obtained are dissolved in 20 ethanolic ammonia. With still gaseous ammonia passing through, the resulting mixture is heated to reflux for 5 hours to give 7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one, which is isolated by prior art. methods. Mp. 212-214 ° C. The yield is 79.2%.

2525

Eksempel 20 I en beholder med et rumfang på 1 liter, der er udstyret med en tilbagesvalingskøler, anbringes der 89,7 g af additionssaltet med formlen 30 H 0 ^______ Jj-C-CHjMj© (CH2)6 Cl© iXc==o o 20Example 20 In a 1 liter container equipped with a reflux condenser, 89.7 g of the addition salt of formula 30 H 0 ^ ______ Jj-C-CHjMj © (CH2) 6 Cl © iXc == oo 20

DK 155326 BDK 155326 B

61,6 g 2-chloracetamido-5-chlorbenzophenon, 22,4 ml 26%'s ammoniumhydroxidopløsning og 425 ml ethanol. Under gennen-ledning af ammoniak opvarmes blandingen i 5 timer til tilbagesvaling. Blandingen inddampes til tørhed, og remanensen 5 opvarmes derefter i 1 time i en blanding af 100 ml toluen og 100 ml vand til tilbagesvaling og afkøles til stuetemperatur. Det derved udfældede produkt skilles fra ved filtrering, vaskes med 20 ml vand og toluen og tørres, hvorved der fås 7-chlor-l,3-dihydro-5-phenyl-2H-l,4-benzodiazepin-2-on 10 med smp. 210-213eC. Udbyttet er 85,4%.61.6 g of 2-chloroacetamido-5-chlorobenzophenone, 22.4 ml of 26% ammonium hydroxide solution and 425 ml of ethanol. Under the conduction of ammonia, the mixture is heated for 5 hours to reflux. The mixture is evaporated to dryness and the residue is then heated for 1 hour in a mixture of 100 ml of toluene and 100 ml of reflux water and cooled to room temperature. The product precipitated is separated by filtration, washed with 20 ml of water and toluene and dried to give 7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one with m.p. . 210-213eC. The yield is 85.4%.

Claims (3)

1. Fremgangsmåde til fremstilling af 1, ^benzodiazepine-on-derivater med den almene formel p 5 (—/ 10 i hvilken R1 betegner hydrogen, halogen, nitro eller tri-fluormethyl, R2 betyder hydrogen eller alkyl med 1-5 car-bonatomer, og R3 betegner phenyl, o-halogenphenyl eller 2-pyridyl, ved omsætning af en forbindelse med den almene 15 formel 2 RO ^___^N-C CH2XA process for the preparation of 1,1'-benzodiazepine-one derivatives of the general formula p 5 (- / 10 in which R 1 represents hydrogen, halogen, nitro or trifluoromethyl, R 2 represents hydrogen or alkyl of 1 to 5 carbon atoms and R 3 represents phenyl, o-halophenyl or 2-pyridyl, by reacting a compound of the general formula 2 RO ^ ___ ^ NC CH2X 20 R1 p i hvilken R1, R2 og R3 har den ovenfor angivne betydning, og X betegner chlor, brom eller iod, fortrinsvis chlor, med 25 hexamethylentetramin i et indifferent organisk opløsningsmiddel, eventuelt under isolering af et mellemprodukt med den almene formel o R O 30 -£"CH2N® ^CH2>6 ^ OLc=o r3 35 i hvilken R1, R2, R3 og X har den ovenfor angivne betydning, DK 155326 B og påfølgende ringslutning deraf til den tilsvarende forbindelse med den almene formel I, kendetegnet ved, at man (a) under den direkte gennemførelse af fremgangsmåden 5 (II-4!) eller - i tilfælde af isolering af mellempro duktet med formlen III - i trinnet (III-*I) og/eller i trinnet (II-»III) arbejder under tilførsel af ammoniak, og at man (b) pr. mol af forbindelsen med formlen II anvender mindst 10 0,1 mol hexamethylentetramin.R 1 in which R 1, R 2 and R 3 have the meaning given above and X represents chlorine, bromine or iodine, preferably chlorine, with 25 hexamethylenetetramine in an inert organic solvent, optionally while isolating an intermediate of the general formula o RO 30 - In which R1, R2, R3 and X are as defined above, DK 155326 B and subsequent cyclization thereof to the corresponding compound of the general formula I, characterized in that (a) during the direct implementation of process 5 (II-4!) or - in the case of isolation of the intermediate of formula III - in step (III-* I) and / or in step (II-III), using ammonia and (b) at least 10 0.1 moles of hexamethylenetetramine are used per mole of the compound of formula II. 2. Fremgangsmåde ifølge krav 1, kendetegnet ved, at der anvendes et udgangsmateriale, hvori R1 betyder chlor, R2 betyder hydrogen, og R3 betyder phenyl.Process according to claim 1, characterized in that a starting material is used, wherein R 1 is chlorine, R 2 is hydrogen and R 3 is phenyl. 3. Fremgangsmåde ifølge krav 1, kendete g-15 net ved, at der anvendes et udgangsmateriale, hvori R1 betyder chlor, R2 betyder methyl og R3 betyder phenyl.3. A process according to claim 1, characterized in that a starting material is used wherein R 1 is chlorine, R 2 is methyl and R 3 is phenyl.
DK457773A 1972-08-21 1973-08-20 METHOD FOR PREPARING 1,4-BENZODIAZEPIN-2-ON DERIVATIVES DK155326C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US28221772A 1972-08-21 1972-08-21
US28221772 1972-08-21
US35981473A 1973-05-14 1973-05-14
US35981473 1973-05-14

Publications (2)

Publication Number Publication Date
DK155326B true DK155326B (en) 1989-03-28
DK155326C DK155326C (en) 1989-08-14

Family

ID=26961312

Family Applications (1)

Application Number Title Priority Date Filing Date
DK457773A DK155326C (en) 1972-08-21 1973-08-20 METHOD FOR PREPARING 1,4-BENZODIAZEPIN-2-ON DERIVATIVES

Country Status (24)

Country Link
JP (1) JPS5911589B2 (en)
AR (1) AR198108A1 (en)
AT (1) AT341527B (en)
AU (1) AU472777B2 (en)
CA (1) CA1012535A (en)
CH (1) CH578544A5 (en)
DD (1) DD107040A5 (en)
DE (1) DE2340159A1 (en)
DK (1) DK155326C (en)
ES (1) ES418014A1 (en)
FI (1) FI57939C (en)
FR (1) FR2197003B1 (en)
GB (1) GB1392681A (en)
HU (1) HU170153B (en)
IE (1) IE38091B1 (en)
IL (1) IL42947A (en)
LU (1) LU68269A1 (en)
NL (1) NL179582C (en)
NO (1) NO139481C (en)
PH (1) PH13640A (en)
PL (1) PL99162B1 (en)
SE (1) SE408302B (en)
SU (1) SU550980A3 (en)
YU (1) YU219873A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5334792A (en) * 1976-09-13 1978-03-31 Scherico Ltd Production of 1*44 benzodiazepines and 1*44 benzodiazepinee22ones
CN113149915B (en) * 2021-03-01 2024-03-15 中国科学院成都有机化学有限公司 Method for synthesizing clonazepam compound
CN116023342B (en) * 2021-10-26 2024-06-25 江苏昱林生物科技有限公司 Preparation method of high-purity clonazepam

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK127428B (en) * 1969-10-16 1973-11-05 Hoffmann La Roche Process for the preparation of 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1136709B (en) * 1959-12-10 1962-09-20 Hoffmann La Roche Process for the preparation of 2-oxo-1, 2-dihydro-1, 4-benzodiazepines
BE785962A (en) * 1971-07-08 1973-01-08 Hoffmann La Roche PROCESS FOR THE PREPARATION OF BENZODIAZEPINE DERIVATIVES

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK127428B (en) * 1969-10-16 1973-11-05 Hoffmann La Roche Process for the preparation of 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one.

Also Published As

Publication number Publication date
NO139481C (en) 1979-03-21
ATA720773A (en) 1977-06-15
JPS5911589B2 (en) 1984-03-16
LU68269A1 (en) 1975-05-21
DE2340159C2 (en) 1989-01-19
NO139481B (en) 1978-12-11
AR198108A1 (en) 1974-05-31
NL179582B (en) 1986-05-01
FI57939B (en) 1980-07-31
IL42947A0 (en) 1973-11-28
GB1392681A (en) 1975-04-30
ES418014A1 (en) 1976-03-16
JPS4956992A (en) 1974-06-03
FR2197003A1 (en) 1974-03-22
CA1012535A (en) 1977-06-21
SE408302B (en) 1979-06-05
FI57939C (en) 1980-11-10
HU170153B (en) 1977-04-28
PL99162B1 (en) 1978-06-30
AU5918073A (en) 1975-02-13
DD107040A5 (en) 1974-07-12
AT341527B (en) 1978-02-10
IL42947A (en) 1977-01-31
YU219873A (en) 1982-06-30
IE38091B1 (en) 1977-12-21
AU472777B2 (en) 1976-06-03
CH578544A5 (en) 1976-08-13
NL7311507A (en) 1974-02-25
DK155326C (en) 1989-08-14
SU550980A3 (en) 1977-03-15
DE2340159A1 (en) 1974-03-07
IE38091L (en) 1974-02-21
FR2197003B1 (en) 1978-01-13
NL179582C (en) 1986-10-01
PH13640A (en) 1980-08-18

Similar Documents

Publication Publication Date Title
Finnegan et al. Preparation and isomerization of 5-alkylaminotetrazoles
CA1067491A (en) Diazepine derivatives
SU507233A3 (en) The method of obtaining derivatives of isoindoline or their salts
DK155326B (en) METHOD FOR PREPARING 1,4-BENZODIAZEPIN-2-ON DERIVATIVES
CA1049009A (en) 6h-thieno (3,2-f)-s-triazolo (4,3-a)-(1,4) diazepines
US3703525A (en) Triazolo(1,5-a)(1,4)benzodiazepine derivatives
US3996209A (en) Process for preparing benzodiazepines
US3202699A (en) Carbobenzoxyglycylamino-benzophenones
US3562325A (en) 2-(n,n-(amino lower alkyl)-(arylsulfonyl))-amino benzophenones and derivatives
US3198789A (en) Certain j-amino-s-phenyl-l,j-dihydro-zh- l,x-benzxraazepin-z-qnx c compounds
US3120521A (en) 2-methyl-7-trifluoromethyl-4h-3, 1 benzoxazine-4-one
US3657223A (en) Process for the preparation of benzodiazepin-2-one derivatives
US3182066A (en) Aminophenyl-pyridyl ketones
US3297685A (en) Process for the preparation of 2-oxo benzodiazepines
US3197467A (en) Process for preparing 1, 3-dihydro-3-hydroxy-2h-1, 4-benzodiazepin-2-ones
US3311612A (en) Process for preparing
US3290292A (en) 1, 1'-lower alkylene-bis
US3513158A (en) Process for preparing 5-aryl benzodiazepines and intermediates
US3849434A (en) Process for preparing triazolobenzodiazepines
JPS61178970A (en) Manufacture of novel 2-substituted 1,4-benzodiazepine
US3501460A (en) Dehydration process for forming benzodiazepines
USRE28315E (en) Cooc.hi
US3439016A (en) 2-amino-2' and 4'-cyanobenzophenones
US3475415A (en) Process for the preparation of 1,3-dihydro-2-oxo-5-aryl - 2h - 1,4 benzodiazepines bearing in the 3-position thereof,an esterified carboxy group
US3576868A (en) Benzoyl amino ethyl aniline derivatives

Legal Events

Date Code Title Description
PBP Patent lapsed